Phoenixville Hospital Supports Colon Cancer Awareness Month
PHOENIXVILLE, PA — Colorectal cancer is the second deadliest cancer in both men and women combined. But it is a highly preventable and treatable disease.
Read MoreColorectal cancer
FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer
WASHINGTON, D.C. — The U.S. Food and Drug Administration this week approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) …
Read More
Idera Pharmaceuticals Announces Tilsotolimod Program Updates to be Presented at AACR Virtual Annual Meeting 2020
EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced that updates on ILLUMINATE-206 and ILLUMINATE-101, two studies investigating intratumoral tilsotolimod, Idera’s investigational Toll-like receptor 9 (TLR9) agonist, will be presented …
Read More
Personalized Cancer Care Offers New Hope for Patients
Elissa Reynolds was preparing to move to Indianapolis and begin an exciting new chapter in her life. Knowing her upcoming move meant she would be without health insurance for a …
Read More